Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Arkeon GmbH is currently managing 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are split between 2 distinct examiners, though both are working within the same 1 distinct art unit. This suggests that while the company is dealing with different individual perspectives, the technical standards and supervisory environment remain consistent within a single art unit.
WILLIAMS, EMMALEE RAE is the busiest examiner for the company, currently overseeing 1 pending office action. With 2 distinct examiners handling one case each, the company must prepare for two different examiner styles. However, because both examiners are in 1 distinct art unit, there may be opportunities for the company to observe consistent internal policies or prior art trends that apply to both pending office actions. This concentration within a single art unit allows for a more unified technical strategy compared to portfolios spread across multiple USPTO divisions. The 2 pending office actions represent a focused effort within the biotechnology sector.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WILLIAMS, EMMALEE RAE | 1 | 0.0% | +0.0% |
| EIX, EMILY FAY | 1 | 45.7% | +76.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18876312 | METHOD FOR PRODUCING AMINO ACIDS IN A BIOREACTOR | WILLIAMS, EMMALEE RAE | — |
| 18876089 | METHOD FOR PRODUCING AMINO ACIDS WITH METHANOGENIC MICROORGANISMS IN A BIOREACTOR | EIX, EMILY FAY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18876089 | METHOD FOR PRODUCING AMINO ACIDS WITH METHANOGENIC MICROORGANISMS IN A BIOREACTOR | EIX, EMILY FAY | — |
| Art Unit | Apps |
|---|---|
| 1653 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18876312 | METHOD FOR PRODUCING AMINO ACIDS IN A BIOREACTOR | WILLIAMS, EMMALEE RAE | 1653 | §101§103§112DP | Non-Final OA | — | Pending | Dec 18, 2024 |
| 18876089 | METHOD FOR PRODUCING AMINO ACIDS WITH METHANOGENIC MICROORGANISMS IN A BIOREACTOR | EIX, EMILY FAY | 1653 | §101§102§112Other | Non-Final OA | — | Pending | Dec 17, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialArkeon GmbH has 2 pending office actions as of October 2026, spread across 1 art units and 2 examiners.
Emmalee Rae Williams has the most, with 1 of Arkeon GmbH's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
